drugset / Trial / NCT00352339

The New Strategy for Pharmacological Treatment in People With Schizophrenia

NCT00352339

Phase 4 Unknown 90 enrolled Inje University
RandomizedParallel-groupDouble-blindTreatment

Summary

Switching from Risperidone to Aripiprazole in early stage of pharmacotherapy will demonstrate the same efficacy as compared to risperidone continuation treatment in the treatment of schizophrenia.

Timeline

Start
2006-08
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified

Indications